口服利福平引起皮下出血1例  

Subcutaneous hemorrhage caused by oral rifampin in 1 case

作　　者：胡春方[1] 胡春光[1] Hu Chunfang;Hu Chunguang(Institute of Prevention and Treatment of Tuberculosis of Liaoyuan City 136200)

机构地区：[1]辽源市结核病防治研究所,136200

出　　处：《中国社区医师》2017年第30期133-134,共2页Chinese Community Doctors

摘　　要：在世界上,结核病被公认为传染病中的"第一号杀手"。结核病患者如果不能彻底治疗就会完全丧失劳动能力和正常学习的机会,而且还会传染他人,对个人和家庭都有极大的危害。结核病治疗的疗程长,使用抗结核药物品种多,易出现药物不良反应,因此及时、合理地处理药物不良反应,是保证结核病患者治疗成功的关键环节。In the world,tuberculosis is recognized as the leading killer in infectious diseases.If tuberculosis patients are not treated thoroughly,they will lose their ability to work and study normally in school,moreover,the disease can infect other people,and it is a great hazard to both the individual and the family.The course of treatment for tuberculosis is long,and the types of anti tuberculosis drugs used are many,and the drugs are prone to adverse reaction,therefore,timely and rational treatment of adverse drug reactions is the key link to ensure the successful treatment of tuberculosis patients.

关 键 词：利福平 不良反应 化疗方案 

分 类 号：R52[医药卫生—内科学]